Abstract:AbstractBackgroundAlzheimer’s disease is the most well‐known disease from ageing. On the Alzheimer’s disease (AD) side, APOE ε4 and TOMM40 rs2075650 are known risk factors from GWAS studies. On the ageing side, mitochondria are theorized to play a central role in the decrease of bioenergy production, rise of oxidative stress and inflammation activation. APOE is an apolipoprotein that facilitates the transportation of cholesterol, which affects the downstream processing of cholesterol in mitochondria. TOMM40 is the channel‐forming subunit of the translocase of the outer mitochondrial membrane complex. It is essential for the import of protein precursors into mitochondria. Interestingly, both genes are also in proximity on chromosome 19 and share linkage disequilibrium. We hypothesize that the two minor alleles work together to influence mitochondrial function.MethodAPOE ε4 and TOMM40 genes are cloned into cDNA plasmids and expressed in cells through transient transfection. Depending on the expression level, this mimics the heterozygous conditions of APOE ε4 and TOMM40 rs2075650 carriers. Mitochondria are fluorescently labeled and imaged for their morphology. The centerline length and average width of mitochondria units are measured to quantify morphology.ResultPreliminary results showed that mitochondria in cells expressing high risk alleles were stressed. The mitochondria appeared swollen with shorter length and wider average width.ConclusionSince dysmorphia is a sure sign of mitochondrial dysfunction and also widely observed in specimen from Alzheimer’s patients, results from heterozygous APOE ε4 and TOMM40 rs2075650 transfected cells may provide insight into the mechanism of AD development. Future study will explore the interaction between the two alleles. The goal is to improve our understanding of the key components of mitochondrial functions and their effects on ageing.

MITOCHONDRIAL SYSTEM BIOLOGY AS A WINDOW INTO DISEASES OF AGING

Mitochondrial-derived peptides in energy metabolism

Mitochondrial-Encoded Peptide MOTS-c, Diabetes, and Aging-Related Diseases

Mitochondrial-derived peptides: Antidiabetic functions and evolutionary perspectives

Mitochondrial peptides modulate mitochondrial function during cellular senescence

The MitoAging Project: Single nucleotide polymorphisms (SNPs) in mitochondrial genes and their association to longevity

Novel Insights into Mitochondrial DNA: Mitochondrial Microproteins and mtDNA Variants Modulate Athletic Performance and Age-Related Diseases

The correlation between mitochondrial derived peptide (MDP) and metabolic states: a systematic review and meta-analysis

Mitochondrial-Derived Peptides Exacerbate Senescence

Mitochondrial miRNA as epigenomic signatures: Visualizing aging-associated heart diseases through a new lens

Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging

Mitochondrial molecular genetics and human disease

MOTS-c Functionally Prevents Metabolic Disorders

MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation

Decoding the mitochondria without a code: mechanistic insights into mitochondrial DNA depletion syndromes

Mitophagy: An Emerging Role in Aging and Age-Associated Diseases

Genetic Contributions of APOE Ε4 and TOMM40 Rs2075650 to Mitochondrial Dysmorphia

Mitochondrial-related microRNAs and their roles in cellular senescence

Mitochondrial-to-nuclear Communication in Aging: an Epigenetic Perspective.

[Research Advances in Human Mitochondrial DNA with Aging and Degenerative Diseases].

A peep into mitochondrial disorder: multifaceted from mitochondrial DNA mutations to nuclear gene modulation